LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway

Table 2

Clinical data of ccRCC patients.

	ccRCC
Total	528
Sex	Male	344
	Female	184
	Unclear	0
Age
	21-40	25
	41-60	239
	61-80	240
	81-100	23
	Unclear	1
Race	Caucasian	459
	African American	54
	Asian	8
	Unclear	8
Stage	I	263
	II	57
	III	123
	IV	82
	Unclear	4
Grade	1	14
	2	229
	3	206
	4	76
	Unclear	3
Survival	Alive	355
	Dead	173
	Unclear	0
Survival time		Days
	Median	1,195.5
	25%	545.25
	75%	1,928.25
	Min	2
	Max	4,537